Let’s start up with the current stock price of Inovio Pharmaceuticals Inc. (INO), which is $1.91 to be very precise. The Stock rose vividly during the last session to $2.04 after opening rate of $1.98 while the lowest price it went was recorded $1.90 before closing at $1.98.Recently in News on July 26, 2022, INOVIO to Report Second Quarter 2022 Financial Results on August 9, 2022. INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect people from infectious diseases and treat people with cancer and HPV-associated diseases, announced today that second quarter 2022 financial results will be released after the market close on August 9, 2022. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. EDT to discuss financial results and provide a general business update. You can read further details here
Inovio Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.2700 on 01/04/22, with the lowest value was $1.3800 for the same time period, recorded on 06/16/22.
Inovio Pharmaceuticals Inc. (INO) full year performance was -77.26%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Inovio Pharmaceuticals Inc. shares are logging -80.82% during the 52-week period from high price, and 38.41% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.38 and $9.96.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4342988 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Inovio Pharmaceuticals Inc. (INO) recorded performance in the market was -61.72%, having the revenues showcasing -30.04% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 470.64M, as it employees total of 317 workers.
Inovio Pharmaceuticals Inc. (INO) in the eye of market guru’s
During the last month, 0 analysts gave the Inovio Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.4804, with a change in the price was noted -1.35. In a similar fashion, Inovio Pharmaceuticals Inc. posted a movement of -41.41% for the period of last 100 days, recording 6,095,319 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for INO is recording 0.05 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.05.
Inovio Pharmaceuticals Inc. (INO): Stocks Technical analysis and Trends
Raw Stochastic average of Inovio Pharmaceuticals Inc. in the period of last 50 days is set at 52.22%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 16.38%. In the last 20 days, the company’s Stochastic %K was 36.95% and its Stochastic %D was recorded 48.61%.
If we look into the earlier routines of Inovio Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -61.72%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -50.77%, alongside a downfall of -77.26% for the period of the last 12 months. The shares increased approximately by -4.98% in the 7-day charts and went down by 10.40% in the period of the last 30 days. Common stock shares were lifted by -30.04% during last recorded quarter.